Literature DB >> 10069879

Differential regulation of antigen-induced IL-4 and IL-13 generation from T lymphocytes by IFN-alpha.

D M Essayan1, G Krishnaswamy, A Oriente, L M Lichtenstein, S K Huang.   

Abstract

BACKGROUND: IL-4 and IL-13 are related cytokines with similar functional properties. Differential regulation of IL-4 and IL-13 has not been described.
OBJECTIVE: We have examined the effects of IFN-alpha on antigen-driven proliferation, IL-4 generation, and IL-13 generation from human PBMCs and T-cell clones.
METHODS: Proliferation was assessed by 3H-thymidine incorporation. Cytokine generation was assessed by reverse transcription PCR and ELISA. Messenger RNA stability was assessed in the presence of actinomycin D.
RESULTS: IFN-alpha induced a concentration-dependent inhibition of antigen-driven proliferation of TH1 and TH2 clones (median effective concentration, 150 to 200 U/mL); the sensitivity of TH1 and TH2 clones to IFN-alpha was not significantly different (P =.6). IFN-alpha induced an analogous concentration-dependent inhibition of antigen-driven IL-13 generation from TH1 and TH2 clones (median effective concentration, 100 U/mL); this effect was evident by 12 hours of culture and persisted beyond 48 hours. However, IL-4 generation from TH2 clones was insensitive to IFN-alpha at all concentrations and times tested (1 to 10,000 U/mL). A similar inhibitory effect of IFN-alpha on mitogen-driven proliferation and IL-13 generation from PBMCs was demonstrated; once again, IL-4 generation from PBMCs was insensitive to IFN-alpha. IL-13 mRNA stability was unaffected by IFN-alpha, suggesting transcriptional regulation.
CONCLUSION: IFN-alpha differentially regulates antigen-stimulated IL-4 and IL-13 generation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10069879     DOI: 10.1016/s0091-6749(99)70470-7

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  6 in total

1.  Respiratory syncytial virus infection induces a subset of types I and III interferons in human dendritic cells.

Authors:  Philippa Hillyer; Viraj P Mane; Aaron Chen; Maria B Dos Santos; Lynnsie M Schramm; Rachel E Shepard; Cindy Luongo; Cyril Le Nouën; Lei Huang; Lihan Yan; Ursula J Buchholz; Ronald G Jubin; Peter L Collins; Ronald L Rabin
Journal:  Virology       Date:  2017-01-31       Impact factor: 3.616

2.  Mycophenolic acid differentially impacts B cell function depending on the stage of differentiation.

Authors:  Jodi L Karnell; Fredrick G Karnell; Geoffrey L Stephens; Bhargavi Rajan; Chris Morehouse; Ying Li; Bonnie Swerdlow; Mildred Wilson; Raphaela Goldbach-Mansky; Christopher Groves; Anthony J Coyle; Ronald Herbst; Rachel Ettinger
Journal:  J Immunol       Date:  2011-08-26       Impact factor: 5.422

3.  Changes in glucose and glutamine lymphocyte metabolisms induced by type I interferon α.

Authors:  Francisco Navarro; Aline V N Bacurau; Andréa Vanzelli; Marcela Meneguello-Coutinho; Marco C Uchida; Milton R Moraes; Sandro S Almeida; Frederick Wasinski; Carlos C Barros; Martin Würtele; Ronaldo C Araújo; Luís F B Costa Rosa; Reury F P Bacurau
Journal:  Mediators Inflamm       Date:  2010-12-27       Impact factor: 4.711

4.  Immunostimulatory oligonucleotides block allergic airway inflammation by inhibiting Th2 cell activation and IgE-mediated cytokine induction.

Authors:  Edith M Hessel; Mabel Chu; Jennifer O Lizcano; Bonnie Chang; Nancy Herman; Sariah A Kell; Marsha Wills-Karp; Robert L Coffman
Journal:  J Exp Med       Date:  2005-11-28       Impact factor: 14.307

5.  A Synthetic Curcuminoid Analogue, 2,6-Bis-4-(Hydroxyl-3-Methoxybenzylidine)-Cyclohexanone (BHMC) Ameliorates Acute Airway Inflammation of Allergic Asthma in Ovalbumin-Sensitized Mice.

Authors:  Chau Ling Tham; Sin Yee Yeoh; Chun Hao Ong; Hanis Hazeera Harith; Daud Ahmad Israf
Journal:  Mediators Inflamm       Date:  2021-04-03       Impact factor: 4.711

6.  Eosinophilia in a patient with cyclical vomiting: a case report.

Authors:  Billy H Copeland; Omolola O Aramide; Salim A Wehbe; S Matthew Fitzgerald; Guha Krishnaswamy
Journal:  Clin Mol Allergy       Date:  2004-05-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.